These proposed mechanisms require functional validation, including studies in diabetic in vivo models such as GC and CYP27A1 knockout mice, and may be further supported by integrative renal omics approaches (e.g., transcriptomics, proteomics, metabolomics) to clarify their role in the pathogenesis of DKD. Here, CYP27A1 is linked to diabetic kidney disease.